GlassScriptPhysician profile
Cheryl F Jones
NPI 1629056395
$6,016.81
in general payments reported to CMS, 2019-2025
15 companies · $24.94 in 2025
The $24.94 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,191 · 2020: $239 · 2021: $391 · 2022: $136 · 2023: $13.77 · 2024: $20.44 · 2025: $24.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $59.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $59.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $4,152.07 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $562.20 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $315.53 | 2019 | |
| Abbvie INC. | $236.75 | 2019-2025 | |
| Lilly USA, LLC | $200.86 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $153.04 | 2021 | |
| Kite Pharma, INC. | $120.90 | 2019 | |
| Tesaro, INC. | $109.49 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $43.89 | 2019 | |
| Exelixis INC. | $41.28 | 2019 | |
| Amgen INC. | $30.09 | 2021-2022 | |
| Daiichi Sankyo INC. | $25.02 | 2019 | |
| Hologic Sales and Service, LLC | $13.77 | 2023 | Trident Specimen Radiography System |
| Gilead Sciences, INC. | $11.92 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.